ATP binding cassette subfamily B member 1, ABCB1
|
Plasma membrane |
Drug efflux [14] |
7q21.12 |
Overexpressed, concrete level not determined [14] |
ATP binding cassette subfamily B member 4, ABCB4 |
Plasma membrane |
Drug efflux [14] |
7q21.12 |
Overexpressed, concrete level not determined [14] |
ATP binding cassette subfamily C member 2, ABCC2
|
Plasma membrane |
Drug efflux [14] |
10q24.2 |
Overexpressed, concrete level not determined [14] |
ATP binding cassette subfamily C member 3, ABCC3
|
Plasma membrane |
Drug efflux [14] |
17q21.33 |
Overexpressed, concrete level not determined [14] |
Abhydrolase domain-containing protein 11, ABHD11
|
Mitochondria |
Putative lipid hydrolase [52] |
7q11.23 |
68% [this paper] |
ATPase family AAA domain-containing protein 3A and 3B, ATAD3A, ATAD3B
|
Mitochondria |
Multiple (mitochondrial network, cristae structure, nucleoid binding) [69,71,72,73,74,75] |
1p36.33 |
154% [this paper] |
Carbamoyl-phosphate synthetase 1, CPS1
|
Mitochondria |
Enzyme (urea cycle) [59,61] |
2q34 |
494% [this paper] |
Cathepsin D, CTSD
|
Lysosomes |
Protein degradation, cell death [40,48,49] |
11p15.5 |
28% [30], 19% [this paper] |
Heat shock protein family B (small) member 1, HSP27
|
Cytosol |
Signaling [30] |
7q11.23 |
47% [30] |
Thyroid hormone receptor interactor 6, TRIP6
|
Cytosol |
Antiapoptotic signaling [30] |
7q22.1 |
650% [30] |